Inclusive Vaccines Alliance reaches agreement with AstraZeneca
Health – Inclusive alliance formed by France, Germany, the Netherlands and Italy agrees a memorandum of understanding with AstraZeneca for buying vaccines – Press release issued by the Ministry for Solidarity and Health and the Ministry of the Economy and Finance
Paris, 13 June 2020
As part of the fight against the COVID-19 pandemic, access to a vaccine will be an essential step towards guaranteeing the protection of our fellow citizens against the pandemic returning. France allied itself with Germany, Italy and the Netherlands in the Inclusive Vaccines Alliance in order to join forces in discussions with pharmaceutical laboratories aimed at guaranteeing supply for the European population as a whole and supporting vaccine projects in development, with a view to global access to the vaccine.
Olivier Véran, Minister for Solidarity and Health, and Agnès Pannier-Runacher, Minister of State attached to the Minister of the Economy and Finance, today announce the signing of an initial agreement with the Alliance for the purchase of SARS-CoV-2 vaccines. The Memorandum of Understanding agreed with the AstraZeneca laboratory provides for AstraZeneca, if its project succeeds, to supply the Alliance with up to 400 million vaccine doses at cost price, which will make it possible to vaccinate those at risk throughout the European Union, with initial deliveries scheduled before the end of 2020.
The agreements concluded by the Alliance countries are intended to serve all European Union member countries and other partner countries wishing to join the initiative. The negotiations were conducted in close coordination with the European Commission and will continue with other pharmaceutical laboratories so that the chances of swiftly having an adequate quantity of vaccine at the best price are maximized.
This contract, from which AstraZeneca has pledged to make no profit, is part of France and the European Union’s efforts to make the COVID-19 vaccine a global public good, accessible to the largest number of people. AstraZeneca has also pledged to supply more than two billion doses at cost price worldwide.
Olivier Véran, Minister for Solidarity and Health, said: “This agreement enables us to secure access to a potential vaccine as a first insurance policy, in a context of strong international competition. We’ll have to continue these negotiations with our partners to reduce the risk of depending on a single project, while securing access to other potential vaccines, and closely follow the scientific progress of the work.”
Agnès Pannier-Runacher, Minister of State attached to the Minister of the Economy and Finance, said: “Under this Memorandum of Understanding, AstraZeneca has pledged to establish a localized supply chain for the vaccine in Europe. If the vaccine is scientifically validated, it will enable us to guarantee our fellow citizens access to it, with tens of millions of doses due to be delivered before the end of 2020. We’ll continue discussions with other laboratories to increase the chances of quickly having an effective vaccine for France and Europe.”./.